Double Blind Placebo Controlled Bellis Perenis and Arnica Montana as a Drug for PPH

Phase 2 Study of the Effect of Bellis Perenis and Arnica Montana on Post Partum Hemmorhage

Status

UNKNOWN

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00405626

Enrollment

210

Registered

2006-11-30

Start date

2007-04-30

Completion date

2007-09-30

Last updated

2006-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemorrhage

Keywords

post partum hemmorhage,Arnica montana,Bellis Perenis

Brief summary

To look at the antihemmorhagic effect of 2 homeopathic drugs in women post delivery Bellis Perenis and Arnica montana

Detailed description

To look at the antihemmorhagic effect of 2 homeopathic drugs in women post delivery Bellis Perenis and Arnica montana compare it with placebo

Interventions

DRUGBellis Perenis ,Arnica montana

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

DOUBLE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* healthy women during delivery

Exclusion criteria

* Scarred uterus, multifetal ,multiparty,bleeding problems,cesarean sectons,chorioamnionitis

Design outcomes

Primary

Measure	Time frame
hemoglobin levels 2 days post partum	—

Secondary

Measure	Time frame
pain	—

Countries

Israel

Contacts

Primary ContactDavid Mankuta, MD

mankuta@yahoo.com5791070

Backup ContactMenachem Oberbaum, MD

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026